Sunshine Lake Pharma Co., Ltd.
Clinical trials sponsored by Sunshine Lake Pharma Co., Ltd., explained in plain language.
-
New insulin biosimilar matches leading drug in diabetes trial
Disease control CompletedThis study tested whether a new insulin blend (22011) works as well and is as safe as the approved insulin Ryzodeg for people with type 2 diabetes. About 414 Chinese adults took part. The goal was to see if the new insulin controls blood sugar similarly over time.
Phase: PHASE3 • Sponsor: Sunshine Lake Pharma Co., Ltd. • Aim: Disease control
Last updated May 26, 2026 04:12 UTC
-
New gout drug HEC93077 passes early safety tests in chinese volunteers
Disease control CompletedThis early-stage trial tested a new drug called HEC93077 in 126 healthy Chinese volunteers and people with high uric acid (hyperuricemia), a condition that can lead to gout. The main goals were to check the drug's safety, how the body processes it, and whether food affects its ab…
Phase: PHASE1 • Sponsor: Sunshine Lake Pharma Co., Ltd. • Aim: Disease control
Last updated May 26, 2026 04:11 UTC
-
New diabetes drug tested in patients with kidney problems
Disease control CompletedThis early-stage study looked at how the drug rongliflozin behaves in 32 people with type 2 diabetes who have normal, mildly, or moderately reduced kidney function. Researchers measured drug levels in the blood and how much sugar was passed in urine after a single dose. The goal …
Phase: PHASE1 • Sponsor: Sunshine Lake Pharma Co., Ltd. • Aim: Disease control
Last updated May 26, 2026 03:55 UTC
-
New hope for lung cancer patients whose treatment stopped working
Disease control CompletedThis study tested a combination of two drugs (ningetinib and gefitinib) in 108 people with advanced non-small cell lung cancer whose tumors had a specific gene change (EGFR mutation) but not another (T790M), and whose cancer had stopped responding to standard targeted therapy. Th…
Phase: PHASE1, PHASE2 • Sponsor: Sunshine Lake Pharma Co., Ltd. • Aim: Disease control
Last updated May 18, 2026 12:00 UTC
-
New sleep pill HEC83518 tested in healthy volunteers
Symptom relief CompletedThis early-stage study tested a new insomnia drug called HEC83518 in 57 healthy Chinese adults aged 18-45. The main goal was to check safety and how the body processes the drug, not to treat insomnia directly. Participants took multiple doses, and researchers monitored side effec…
Phase: PHASE1 • Sponsor: Sunshine Lake Pharma Co., Ltd. • Aim: Symptom relief
Last updated May 26, 2026 04:11 UTC
-
New sleep aid HEC83518 passes early safety check in healthy volunteers
Symptom relief CompletedThis early-stage study tested a new insomnia drug called HEC83518 in 74 healthy Chinese adults aged 18-45. The main goal was to check safety and side effects, not to measure how well it works. Researchers gave single rising doses to see how the body processes the drug.
Phase: PHASE1 • Sponsor: Sunshine Lake Pharma Co., Ltd. • Aim: Symptom relief
Last updated May 18, 2026 12:12 UTC
-
Healthy volunteers help test new Brain-Targeting drug
Knowledge-focused CompletedThis early-stage study tested a new drug called HEC30654AcOH in 43 healthy adults to see if it is safe and how the body processes it. Participants received either single or multiple doses of the drug or a placebo. The main goal was to check for side effects and measure drug level…
Phase: PHASE1 • Sponsor: Sunshine Lake Pharma Co., Ltd. • Aim: Knowledge-focused
Last updated May 26, 2026 04:16 UTC
-
Healthy volunteers help uncover drug interactions for lung disease therapy
Knowledge-focused CompletedThis study looked at how a new medicine called HEC585 interacts with two existing drugs (pirfenidone and nintedanib) used for idiopathic pulmonary fibrosis (IPF), a serious lung disease. Thirty-three healthy adults took part to measure drug levels and check for side effects. The …
Phase: PHASE1 • Sponsor: Sunshine Lake Pharma Co., Ltd. • Aim: Knowledge-focused
Last updated May 26, 2026 03:55 UTC
-
Liver damage may change how diabetes drug works – early study completed
Knowledge-focused CompletedThis early-stage study looked at how the diabetes drug rongliflozin is processed in people with mild or moderate liver damage compared to healthy people. 32 adults took a single dose, and researchers measured drug levels and side effects. The goal was to gather safety and dosing …
Phase: PHASE1 • Sponsor: Sunshine Lake Pharma Co., Ltd. • Aim: Knowledge-focused
Last updated May 22, 2026 13:52 UTC
-
Healthy men help unravel Drug's journey through the body
Knowledge-focused CompletedThis study looked at how the experimental drug clifutinib moves through and leaves the bodies of 6 healthy men. Participants took a single radioactive dose so researchers could track the drug in blood, urine, and stool. The goal was to understand how the drug is broken down and e…
Phase: PHASE1 • Sponsor: Sunshine Lake Pharma Co., Ltd. • Aim: Knowledge-focused
Last updated May 11, 2026 20:50 UTC